Changes in mobility patterns during the COVID-19 pandemic in Zambia: Implications for the effectiveness of NPIs in Sub-Saharan Africa.
Journal
PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676
Informations de publication
Date de publication:
2023
2023
Historique:
received:
18
07
2022
accepted:
22
09
2023
medline:
31
10
2023
pubmed:
31
10
2023
entrez:
31
10
2023
Statut:
epublish
Résumé
The COVID-19 pandemic has impacted many facets of human behavior, including human mobility partially driven by the implementation of non-pharmaceutical interventions (NPIs) such as stay at home orders, travel restrictions, and workplace and school closures. Given the importance of human mobility in the transmission of SARS-CoV-2, there have been an increase in analyses of mobility data to understand the COVID-19 pandemic to date. However, despite an abundance of these analyses, few have focused on Sub-Saharan Africa (SSA). Here, we use mobile phone calling data to provide a spatially refined analysis of sub-national human mobility patterns during the COVID-19 pandemic from March 2020-July 2021 in Zambia using transmission and mobility models. Overall, among highly trafficked intra-province routes, mobility decreased up to 52% during the time of the strictest NPIs (March-May 2020) compared to baseline. However, despite dips in mobility during the first wave of COVID-19 cases, mobility returned to baseline levels and did not drop again suggesting COVID-19 cases did not influence mobility in subsequent waves.
Identifiants
pubmed: 37906535
doi: 10.1371/journal.pgph.0000892
pii: PGPH-D-22-01142
pmc: PMC10617722
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e0000892Informations de copyright
Copyright: © 2023 Loisate et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLOS Glob Public Health. 2022 Sep 13;2(9):e0000502
pubmed: 36962513
Sci Rep. 2021 Jun 29;11(1):13531
pubmed: 34188119
Nat Hum Behav. 2021 Apr;5(4):529-538
pubmed: 33686204
Front Pharmacol. 2020 Sep 11;11:1205
pubmed: 33071775
JMIR Public Health Surveill. 2021 Aug 30;7(8):e29957
pubmed: 34174780
Science. 2021 Feb 19;371(6531):
pubmed: 33323424
PLoS One. 2022 Feb 25;17(2):e0264455
pubmed: 35213645
Epidemiol Infect. 2020 Oct 08;148:e249
pubmed: 33028445
Lancet Glob Health. 2021 Jun;9(6):e773-e781
pubmed: 33711262
Cell. 2021 Dec 22;184(26):6229-6242.e18
pubmed: 34910927
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114